Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group

HT Mouridsen, L Bastholt, R Somers, A Santoro… - European Journal of …, 1987 - Elsevier
The objective of this randomized phase II/phase III study was to investigate the efficacy and
toxicity of equimolar doses of adriamycin (ADM) and 4-epiadriamycin (EPI) in patients with …
被引用次数：191 相关文章

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group.

HT Mouridsen, L Bastholt, R Somers… - European Journal of …, 1987 - europepmc.org
The objective of this randomized phase II/phase III study was to investigate the efficacy and
toxicity of equimolar doses of adriamycin (ADM) and 4-epiadriamycin (EPI) in patients with …

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group

HT Mouridsen, L Bastholt, R Somers… - … Journal of Cancer …, 1987 - pure.johnshopkins.edu
The objective of this randomized phase II/phase III study was to investigate the efficacy and
toxicity of equimolar doses of adriamycin (ADM) and 4-epiadriamycin (EPI) in patients with …

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group.

M HT, L Bastholt, R Somers, A Santoro… - … OF CANCER & …, 1987 - iris.hunimed.eu
The objective of this randomized phase II/phase III study was to investigate the efficacy and
toxicity of equimolar doses of adriamycin (ADM) and 4-epiadriamycin (EPI) in patients with …

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group

HT Mouridsen, L Bastholt, R Somers… - … journal of cancer & …, 1987 - pubmed.ncbi.nlm.nih.gov
The objective of this randomized phase II/phase III study was to investigate the efficacy and
toxicity of equimolar doses of adriamycin (ADM) and 4-epiadriamycin (EPI) in patients with …

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group

HT Mouridsen, L Bastholt, R Somers… - European Journal of …, 1987 - ejcancer.com
The objective of this randomized phase II/phase III study was to investigate the efficacy and
toxicity of equimolar doses of adriamycin (ADM) and 4-epiadriamycin (EPI) in patients with …

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group.

HT Mouridsen, L Bastholt, R Somers, A Santoro… - 1987 - christie.openrepository.com
The objective of this randomized phase II/phase III study was to investigate the efficacy and
toxicity of equimolar doses of adriamycin (ADM) and 4-epiadriamycin (EPI) in patients with …

[引用][C] Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group

HT Mouridsen, L Bastholt, R Somers… - European Journal of …, 1987 - cir.nii.ac.jp
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase
III study of the EORTC soft tissue and bone sarcoma group | CiNii Research CiNii 国立 …

[引用][C] Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group

HT MOURIDSEN, L BASTHOLT… - European journal of …, 1987 - pascal-francis.inist.fr
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III
study of the EORTC soft tissue and bone sarcoma group CNRS Inist Pascal-Francis CNRS …